Abstract
Personalized medicine is a translational approach that utilizes an individual’s genetic profile to guide illness prevention, diagnosis, and treatment choices. The human genome project data is being used to enhance personalized treatment. “Personalised” medicine is beneficial over “individualized” medicine as it suggests that future hazards may be predicted based on the individual’s genes. The advancement of technology for personalized medicine depends heavily on standardization, integration, and harmonization. The scientific practices at various research sites, the connection between science and healthcare, and the relationship between science, healthcare, and broader society, including the legal and ethical paradigms, the dominant cultural and political ethos, and the expectations of patients and citizens - all need to be in harmony. There are several descriptions of the current existing legislation that regulates genetic screening and genomic medical services in various countries around the world, highlighting discrepancies and specifying areas of law where harmonization may be needed to enable the use of individually tailored medication globally. The promise of personalized medicine can only be fulfilled by placing the individual at the centre of personalized medicine and tailoring care to each patient’s unique psychological and social needs in addition to their biological profiles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.